Sg Americas Securities, LLC Repligen Corp Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Repligen Corp stock. As of the latest transaction made, Sg Americas Securities, LLC holds 3,447 shares of RGEN stock, worth $553,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,447
Previous 6,520 47.13%
Holding current value
$553,277
Previous $970,000 48.87%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
SELL
$123.41 - $160.92 $379,238 - $494,507
-3,073 Reduced 47.13%
3,447 $496,000
Q3 2024

Oct 03, 2024
BUY
$119.79 - $167.35 $443,342 - $619,362
3,701 Added 131.29%
6,520 $970,000
Q2 2024

Jul 12, 2024
SELL
$120.0 - $182.95 $110,280 - $168,131
-919 Reduced 24.59%
2,819 $355,000
Q1 2024

May 06, 2024
SELL
$170.78 - $208.42 $564,257 - $688,619
-3,304 Reduced 46.92%
3,738 $687,000
Q4 2023

Jan 12, 2024
SELL
$114.17 - $185.35 $2.29 Million - $3.72 Million
-20,073 Reduced 74.03%
7,042 $1.27 Million
Q3 2023

Oct 13, 2023
BUY
$138.78 - $176.51 $3.76 Million - $4.79 Million
27,115 New
27,115 $4.31 Million
Q1 2023

Apr 28, 2023
BUY
$154.26 - $198.1 $608,401 - $781,306
3,944 Added 116.24%
7,337 $1.24 Million
Q4 2022

Feb 02, 2023
SELL
$162.42 - $220.56 $174,439 - $236,881
-1,074 Reduced 24.04%
3,393 $574,000
Q3 2022

Oct 31, 2022
SELL
$160.42 - $256.21 $727,023 - $1.16 Million
-4,532 Reduced 50.36%
4,467 $836,000
Q2 2022

Jul 29, 2022
BUY
$140.68 - $188.02 $660,492 - $882,753
4,695 Added 109.08%
8,999 $1.46 Million
Q1 2022

Apr 29, 2022
SELL
$161.19 - $257.96 $3.22 Million - $5.15 Million
-19,978 Reduced 82.27%
4,304 $810,000
Q4 2021

Feb 07, 2022
BUY
$247.59 - $304.47 $4.52 Million - $5.56 Million
18,271 Added 303.96%
24,282 $6.43 Million
Q3 2021

Nov 01, 2021
SELL
$194.77 - $324.21 $1.41 Million - $2.35 Million
-7,237 Reduced 54.63%
6,011 $1.74 Million
Q2 2021

Aug 12, 2021
BUY
$165.87 - $220.95 $129,876 - $173,003
783 Added 6.28%
13,248 $2.65 Million
Q1 2021

May 13, 2021
SELL
$180.37 - $226.26 $6.01 Million - $7.54 Million
-33,322 Reduced 72.78%
12,465 $2.42 Million
Q4 2020

Feb 04, 2021
BUY
$148.08 - $206.57 $6.64 Million - $9.27 Million
44,852 Added 4797.01%
45,787 $8.77 Million
Q3 2020

Nov 09, 2020
SELL
$122.51 - $158.27 $3.79 Million - $4.9 Million
-30,964 Reduced 97.07%
935 $138,000
Q2 2020

Jul 20, 2020
BUY
$94.33 - $140.48 $667,762 - $994,457
7,079 Added 28.52%
31,899 $3.94 Million
Q1 2020

Apr 30, 2020
BUY
$84.96 - $109.14 $1.32 Million - $1.69 Million
15,493 Added 166.11%
24,820 $2.4 Million
Q4 2019

Jan 28, 2020
SELL
$73.84 - $93.08 $161,045 - $203,007
-2,181 Reduced 18.95%
9,327 $863,000
Q3 2019

Nov 04, 2019
BUY
$76.65 - $95.51 $615,116 - $766,467
8,025 Added 230.4%
11,508 $883,000
Q2 2019

Jul 29, 2019
SELL
$54.2 - $85.95 $36,314 - $57,586
-670 Reduced 16.13%
3,483 $299,000
Q1 2019

Apr 29, 2019
SELL
$49.45 - $62.8 $1 Million - $1.27 Million
-20,288 Reduced 83.01%
4,153 $245,000
Q4 2018

Feb 01, 2019
BUY
$48.26 - $68.88 $1.18 Million - $1.68 Million
24,441 New
24,441 $1.29 Million
Q3 2018

Nov 06, 2018
SELL
$46.8 - $58.97 $134,550 - $169,538
-2,875 Closed
0 $0
Q2 2018

Aug 07, 2018
BUY
$35.26 - $47.04 $101,372 - $135,240
2,875 New
2,875 $135,000
Q4 2017

Jan 24, 2018
SELL
$32.53 - $38.92 $153,053 - $183,118
-4,705 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$36.98 - $46.06 $173,990 - $216,712
4,705
4,705 $180,000

Others Institutions Holding RGEN

# of Institutions
489
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email